00014035682022Q2--01-28false0001403568us-gaap:TreasuryStockCommonMember2022-05-012022-07-300001403568us-gaap:TreasuryStockCommonMember2022-01-302022-04-300001403568us-gaap:TreasuryStockCommonMember2021-05-022021-07-310001403568us-gaap:TreasuryStockCommonMember2021-01-312021-05-010001403568ulta:ShareRepurchaseProgram2022Member2022-03-310001403568ulta:ShareRepurchaseProgram2020Member2020-03-120001403568us-gaap:TreasuryStockCommonMember2022-07-300001403568us-gaap:RetainedEarningsMember2022-07-300001403568us-gaap:AdditionalPaidInCapitalMember2022-07-300001403568us-gaap:TreasuryStockCommonMember2022-04-300001403568us-gaap:RetainedEarningsMember2022-04-300001403568us-gaap:AdditionalPaidInCapitalMember2022-04-300001403568us-gaap:TreasuryStockCommonMember2022-01-290001403568us-gaap:RetainedEarningsMember2022-01-290001403568us-gaap:AdditionalPaidInCapitalMember2022-01-290001403568us-gaap:TreasuryStockCommonMember2021-07-310001403568us-gaap:RetainedEarningsMember2021-07-310001403568us-gaap:AdditionalPaidInCapitalMember2021-07-310001403568us-gaap:TreasuryStockCommonMember2021-05-010001403568us-gaap:RetainedEarningsMember2021-05-010001403568us-gaap:AdditionalPaidInCapitalMember2021-05-010001403568us-gaap:TreasuryStockCommonMember2021-01-300001403568us-gaap:RetainedEarningsMember2021-01-300001403568us-gaap:AdditionalPaidInCapitalMember2021-01-300001403568us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-300001403568stpr:WY2022-07-300001403568stpr:WV2022-07-300001403568stpr:WI2022-07-300001403568stpr:WA2022-07-300001403568stpr:VT2022-07-300001403568stpr:VA2022-07-300001403568stpr:UT2022-07-300001403568stpr:TX2022-07-300001403568stpr:TN2022-07-300001403568stpr:SD2022-07-300001403568stpr:SC2022-07-300001403568stpr:RI2022-07-300001403568stpr:PA2022-07-300001403568stpr:OR2022-07-300001403568stpr:OK2022-07-300001403568stpr:OH2022-07-300001403568stpr:NY2022-07-300001403568stpr:NV2022-07-300001403568stpr:NM2022-07-300001403568stpr:NJ2022-07-300001403568stpr:NH2022-07-300001403568stpr:NE2022-07-300001403568stpr:ND2022-07-300001403568stpr:NC2022-07-300001403568stpr:MT2022-07-300001403568stpr:MS2022-07-300001403568stpr:MO2022-07-300001403568stpr:MN2022-07-300001403568stpr:MI2022-07-300001403568stpr:ME2022-07-300001403568stpr:MD2022-07-300001403568stpr:MA2022-07-300001403568stpr:LA2022-07-300001403568stpr:KY2022-07-300001403568stpr:KS2022-07-300001403568stpr:IN2022-07-300001403568stpr:IL2022-07-300001403568stpr:ID2022-07-300001403568stpr:IA2022-07-300001403568stpr:HI2022-07-300001403568stpr:GA2022-07-300001403568stpr:FL2022-07-300001403568stpr:DE2022-07-300001403568stpr:CT2022-07-300001403568stpr:CO2022-07-300001403568stpr:CA2022-07-300001403568stpr:AZ2022-07-300001403568stpr:AR2022-07-300001403568stpr:AL2022-07-300001403568stpr:AK2022-07-300001403568us-gaap:RetainedEarningsMember2022-05-012022-07-300001403568us-gaap:RetainedEarningsMember2022-01-302022-04-300001403568us-gaap:RetainedEarningsMember2021-05-022021-07-310001403568us-gaap:RetainedEarningsMember2021-01-312021-05-010001403568ulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-01-302022-07-300001403568us-gaap:RevolvingCreditFacilityMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-07-300001403568us-gaap:LetterOfCreditMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-07-300001403568us-gaap:RevolvingCreditFacilityMember2022-07-300001403568us-gaap:RevolvingCreditFacilityMember2022-01-290001403568us-gaap:RevolvingCreditFacilityMember2021-07-310001403568us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-312021-05-010001403568us-gaap:FairValueInputsLevel2Memberus-gaap:NonqualifiedPlanMember2022-07-300001403568us-gaap:FairValueInputsLevel2Memberus-gaap:NonqualifiedPlanMember2022-01-290001403568us-gaap:FairValueInputsLevel2Memberus-gaap:NonqualifiedPlanMember2021-07-310001403568us-gaap:RestrictedStockUnitsRSUMember2022-07-300001403568us-gaap:PerformanceSharesMember2022-07-300001403568us-gaap:EmployeeStockOptionMember2022-07-300001403568srt:MinimumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-302022-07-300001403568srt:MinimumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:BaseRateMember2022-01-302022-07-300001403568srt:MaximumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-302022-07-300001403568srt:MaximumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:BaseRateMember2022-01-302022-07-3000014035682022-04-3000014035682021-05-010001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-05-012022-07-300001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-07-300001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-05-022021-07-310001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-07-310001403568us-gaap:CommonStockMember2022-07-300001403568us-gaap:CommonStockMember2022-04-300001403568us-gaap:CommonStockMember2022-01-290001403568us-gaap:CommonStockMember2021-07-310001403568us-gaap:CommonStockMember2021-05-010001403568us-gaap:CommonStockMember2021-01-3000014035682021-01-300001403568us-gaap:RestrictedStockUnitsRSUMember2022-05-012022-07-300001403568us-gaap:PerformanceSharesMember2022-05-012022-07-300001403568us-gaap:EmployeeStockOptionMember2022-05-012022-07-300001403568us-gaap:RestrictedStockUnitsRSUMember2022-01-302022-07-300001403568us-gaap:PerformanceSharesMember2022-01-302022-07-300001403568us-gaap:EmployeeStockOptionMember2022-01-302022-07-300001403568us-gaap:RestrictedStockUnitsRSUMember2021-05-022021-07-310001403568us-gaap:PerformanceSharesMember2021-05-022021-07-310001403568us-gaap:EmployeeStockOptionMember2021-05-022021-07-310001403568us-gaap:RestrictedStockUnitsRSUMember2021-01-312021-07-310001403568us-gaap:PerformanceSharesMember2021-01-312021-07-310001403568us-gaap:EmployeeStockOptionMember2021-01-312021-07-3100014035682022-07-3000014035682022-01-2900014035682021-07-310001403568us-gaap:CommonStockMember2022-05-012022-07-300001403568us-gaap:AdditionalPaidInCapitalMember2022-05-012022-07-300001403568us-gaap:CommonStockMember2022-01-302022-04-300001403568us-gaap:AdditionalPaidInCapitalMember2022-01-302022-04-3000014035682022-01-302022-04-300001403568us-gaap:CommonStockMember2021-05-022021-07-310001403568us-gaap:AdditionalPaidInCapitalMember2021-05-022021-07-310001403568us-gaap:CommonStockMember2021-01-312021-05-010001403568us-gaap:AdditionalPaidInCapitalMember2021-01-312021-05-0100014035682021-01-312021-05-010001403568us-gaap:RevolvingCreditFacilityMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-01-302022-07-3000014035682022-05-012022-07-3000014035682021-05-022021-07-310001403568srt:MinimumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-01-302022-07-3000014035682021-01-312021-07-3100014035682022-08-2200014035682022-01-302022-07-30xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharesulta:stateulta:store

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended July 30, 2022

or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _____________ to _____________

Commission File Number: 001-33764

ULTA BEAUTY, INC.

(Exact name of Registrant as specified in its charter)


incorporation or organization)


Identification No.)

Delaware

(State or other jurisdiction of
incorporation or organization)

38-4022268

(I.R.S. Employer
Identification No.)

1000 Remington Blvd., Suite 120

Bolingbrook, Illinois

(Address of principal executive offices)

60440

(Zip code)

Registrant’s telephone number, including area code: (630) 410-4800

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.01 per share

ULTA

The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer      Accelerated filer      Non-accelerated filer      Smaller reporting company       Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No

The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding as of August 22, 2022 was 51,221,498 shares.

Table of Contents

ULTA BEAUTY, INC.

TABLE OF CONTENTS

Part I - Financial Information

Item 1.    Financial Statements

Consolidated Balance Sheets

3

Consolidated Statements of Income

4

Consolidated Statements of Cash Flows

5

Consolidated Statements of Stockholders’ Equity

6

Notes to Consolidated Financial Statements

8

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3.    Quantitative and Qualitative Disclosures about Market Risk

24

Item 4.    Controls and Procedures

25

Part II - Other Information

25

Item 1.    Legal Proceedings

25

Item 1A. Risk Factors

25

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

25

Item 3.    Defaults Upon Senior Securities

26

Item 4.    Mine Safety Disclosures

26

Item 5.    Other Information

26

Item 6.    Exhibits

27

SIGNATURES

28

2

Table of Contents

Part I - Financial Information

Item 1.Financial Statements

Ulta Beauty, Inc.

Consolidated Balance Sheets

July 30,

January 29,

July 31,

(In thousands, except per share data)

    

2022

    

2022

    

2021

Assets

(Unaudited)

(Unaudited)

Current assets:

Cash and cash equivalents

$

434,226

$

431,560

$

770,144

Receivables, net

180,514

233,682

154,416

Merchandise inventories, net

1,666,130

1,499,218

1,443,685

Prepaid expenses and other current assets

123,014

110,814

108,145

Prepaid income taxes

39,029

5,909

18,544

Total current assets

2,442,913

2,281,183

2,494,934

Property and equipment, net

912,017

914,476

909,507

Operating lease assets

1,509,246

1,482,256

1,470,166

Goodwill

10,870

10,870

10,870

Other intangible assets, net

1,075

1,538

2,001

Deferred compensation plan assets

33,393

38,409

36,396

Other long-term assets

36,480

35,647

30,711

Total assets

$

4,945,994

$

4,764,379

$

4,954,585

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

586,851

$

552,730

$

535,257

Accrued liabilities

323,939

364,797

313,372

Deferred revenue

316,571

353,579

265,462

Current operating lease liabilities

274,693

274,118

267,442

Accrued income taxes

12,786

Total current liabilities

1,502,054

1,558,010

1,381,533

Non-current operating lease liabilities

1,582,003

1,572,638

1,585,539

Deferred income taxes

40,029

39,693

64,535

Other long-term liabilities

52,840

58,665

43,165

Total liabilities

3,176,926

3,229,006

3,074,772

Commitments and contingencies (Note 6)

Stockholders' equity:

Common stock, $0.01 par value, 400,000 shares authorized; 52,087, 53,049, and 55,160 shares issued; 51,332, 52,311, and 54,446 shares outstanding; at July 30, 2022 (unaudited), January 29, 2022, and July 31, 2021 (unaudited), respectively

521

530

551

Treasury stock-common, at cost

(59,803)

(53,478)

(44,775)

Additional paid-in capital

982,339

934,945

889,206

Retained earnings

846,011

653,376

1,034,831

Total stockholders’ equity

1,769,068

1,535,373

1,879,813

Total liabilities and stockholders’ equity

$

4,945,994

$

4,764,379

$

4,954,585

See accompanying notes to consolidated financial statements.

3

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Income

(Unaudited)

13 Weeks Ended

26 Weeks Ended

July 30,

July 31,

July 30,

July 31,

(In thousands, except per share data)

    

2022

2021

2022

2021

Net sales

$

2,297,113

$

1,967,207

$

4,643,014

$

3,905,726

Cost of sales

1,368,949

1,169,244

2,773,824

2,353,975

Gross profit

928,164

797,963

1,869,190

1,551,751

Selling, general and administrative expenses

534,459

464,299

1,035,429

908,174

Pre-opening expenses

2,277

1,357

4,625

5,946

Operating income

391,428

332,307

829,136

637,631

Interest expense (income), net

(108)

425

293

783

Income before income taxes

391,536

331,882

828,843

636,848

Income tax expense

95,859

80,989

201,771

155,666

Net income

$

295,677

$

250,893

$

627,072

$

481,182

Net income per common share:

Basic

$

5.73

$

4.59

$

12.08

$

8.71

Diluted

$

5.70

$

4.56

$

12.00

$

8.66

Weighted average common shares outstanding:

Basic

51,607

54,675

51,928

55,235

Diluted

51,900

55,014

52,237

55,592

See accompanying notes to consolidated financial statements.

4

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

26 Weeks Ended

July 30,

July 31,

(In thousands)

    

2022

    

2021

Operating activities

Net income

$

627,072

$

481,182

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

123,721

139,577

Non-cash lease expense

146,251

137,521

Deferred income taxes

336

(824)

Stock-based compensation expense

22,875

19,097

Loss on disposal of property and equipment

2,277

1,703

Change in operating assets and liabilities:

Receivables

53,168

38,693

Merchandise inventories

(166,912)

(275,470)

Prepaid expenses and other current assets

(12,200)

(741)

Income taxes

(45,906)

(61,074)

Accounts payable

40,051

59,360

Accrued liabilities

(49,364)

17,858

Deferred revenue

(37,008)

(8,921)

Operating lease liabilities

(163,302)

(146,892)

Other assets and liabilities

(392)

344

Net cash provided by operating activities

540,667

401,413

Investing activities

Capital expenditures

(120,500)

(57,305)

Other investments

(1,249)

Net cash used in investing activities

(121,749)

(57,305)

Financing activities

Repurchase of common shares

(434,448)

(635,793)

Stock options exercised

24,521

22,808

Purchase of treasury shares

(6,325)

(6,974)

Net cash used in financing activities

(416,252)

(619,959)

Effect of exchange rate changes on cash and cash equivalents

(56)

Net increase (decrease) in cash and cash equivalents

2,666

(275,907)

Cash and cash equivalents at beginning of period

431,560

1,046,051

Cash and cash equivalents at end of period

$

434,226

$

770,144

Supplemental information

Cash paid for interest

$

1,057

$

1,057

Income taxes paid, net of refunds

    

246,641

216,831

Non-cash capital expenditures

42,451

18,511

See accompanying notes to consolidated financial statements.

5

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Stockholders’ Equity

(Unaudited)

Treasury -

Common Stock

Common Stock

Additional

Total

Issued

Treasury

Paid-In

Retained

Stockholders'

(In thousands)

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Earnings

    

Equity

Balance – January 29, 2022

53,049

$

530

(738)

$

(53,478)

$

934,945

$

653,376

$

1,535,373

Net income

331,395

331,395

Stock-based compensation

10,356

10,356

Stock options exercised and other awards

73

1

6,501

6,502

Purchase of treasury shares

(14)

(5,172)

(5,172)

Repurchase of common shares

(332)

(3)

(132,831)

(132,834)

Balance – April 30, 2022

52,790

$

528

(752)

$

(58,650)

$

951,802

$

851,940

$

1,745,620

Net income

295,677

295,677

Stock-based compensation

12,519

12,519

Stock options exercised and other awards

95

1

18,018

18,019

Purchase of treasury shares

(3)

(1,153)

(1,153)

Repurchase of common shares

(798)

(8)

(301,606)

(301,614)

Balance – July 30, 2022

52,087

$

521

(755)

$

(59,803)

$

982,339

$

846,011

$

1,769,068

See accompanying notes to consolidated financial statements.

6

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Stockholders’ Equity

(Unaudited)

Treasury -

Accumulated

Common Stock

Common Stock

Additional

Other

Total

Issued

Treasury

Paid-In

Retained

Comprehensive

Stockholders'

(In thousands)

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Earnings

    

Income (Loss)

    

Equity

Balance – January 30, 2021

56,952

$

569

(692)

$

(37,801)

$

847,303

$

1,189,422

$

56

$

1,999,549

Net income

230,289

230,289

Stock-based compensation

8,978

8,978

Foreign currency translation adjustments

(56)

(56)

Stock options exercised and other awards

94

1

5,031

5,032

Purchase of treasury shares

(21)

(6,766)

(6,766)

Repurchase of common shares

(1,243)

(12)

(392,297)

(392,309)

Balance – May 1, 2021

55,803

$

558

(713)

$

(44,567)

$

861,312

$

1,027,414

$

$

1,844,717

Net income

250,893

250,893

Stock-based compensation

10,119

10,119

Stock options exercised and other awards

104

1

17,775

17,776

Purchase of treasury shares

(1)

(208)

(208)

Repurchase of common shares

(747)

(8)

(243,476)

(243,484)

Balance – July 31, 2021

55,160

$

551

(714)

$

(44,775)

$

889,206

$

1,034,831

$

$

1,879,813

See accompanying notes to consolidated financial statements.

7

Table of Contents

Ulta Beauty, Inc.

Notes to Consolidated Financial Statements

(In thousands, except per share and store count data) (Unaudited)

1.Business and basis of presentation

Ulta Beauty, Inc. was founded in 1990 to operate specialty retail stores selling cosmetics, fragrance, haircare and skincare products, and related accessories and services. The stores also feature full-service salons. As used in these notes and throughout this Quarterly Report on Form 10-Q, all references to “we,” “us,” “our,” “Ulta Beauty,” or the “Company” refer to Ulta Beauty, Inc. and its consolidated subsidiaries.

As of July 30, 2022, the Company operated 1,325 stores across 50 states, as shown in the table below.

Number of

Number of

Location

    

stores

    

Location

    

stores

Alabama

24

Montana

6

Alaska

3

Nebraska

5

Arizona

31

Nevada

16

Arkansas

11

New Hampshire

8

California

165

New Jersey

44

Colorado

26

New Mexico

7

Connecticut

19

New York

52

Delaware

3

North Carolina

40

Florida

91

North Dakota

4

Georgia

43

Ohio

45

Hawaii

4

Oklahoma

21

Idaho

9

Oregon

16

Illinois

55

Pennsylvania

45

Indiana

24

Rhode Island

4

Iowa

11

South Carolina

24

Kansas

13

South Dakota

3

Kentucky

15

Tennessee

28

Louisiana

18

Texas

120

Maine

3

Utah

15

Maryland

28

Vermont

1

Massachusetts

23

Virginia

32

Michigan

49

Washington

36

Minnesota

19

West Virginia

7

Mississippi

11

Wisconsin

20

Missouri

25

Wyoming

3

Total

1,325

The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and the U.S. Securities and Exchange Commission’s Article 10, Regulation S-X. These financial statements were prepared on a consolidated basis to include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts, transactions, and unrealized profit were eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to fairly state the financial position and results of operations and cash flows for the interim periods presented.

8

Table of Contents

The Company’s business is subject to seasonal fluctuation, with significant portions of net sales and net income being realized during the fourth quarter of the fiscal year due to the holiday selling season. The results for the 13 and 26 weeks ended July 30, 2022 are not necessarily indicative of the results to be expected for the fiscal year ending January 28, 2023, or for any other future interim period or for any future year, in particular as a result of the uncertainty around the continuing effects of the COVID-19 pandemic, geo-political events, and inflationary cost pressures on future periods.

These unaudited interim consolidated financial statements and the related notes should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended January 29, 2022. All amounts are stated in thousands, with the exception of per share amounts and number of stores.

2.Summary of significant accounting policies

Information regarding significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Annual Report on Form 10-K for the year ended January 29, 2022. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Consolidated Financial Statements” in the Annual Report.

Fiscal quarter

The Company’s quarterly periods are the 13 weeks ending on the Saturday closest to April 30, July 31, October 31, and January 31. The second quarter in fiscal 2022 and 2021 ended on July 30, 2022 and July 31, 2021, respectively.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results could differ from those estimates. The Company considers its accounting policies relating to inventory valuations, vendor allowances, impairment of long-lived tangible and right-of-use assets, loyalty program and income taxes to be the most significant accounting policies that involve management estimates and judgments. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment, including those related to the impacts of the COVID-19 pandemic, geo-political events, and inflationary cost pressures, will be reflected in the consolidated financial statements in future periods.

9

Table of Contents

3.Revenue

Net sales include retail stores and e-commerce merchandise sales as well as salon services and other revenue. Other revenue includes the private label and co-branded credit card programs, royalties derived from the partnership with Target, and deferred revenue related to the loyalty program and gift card breakage.

Disaggregated revenue

The following table sets forth the approximate percentage of net sales by primary category:

13 Weeks Ended  

26 Weeks Ended

July 30,

July 31,

July 30,

July 31,

(Percentage of net sales)

2022

2021

2022

2021

Cosmetics

42%

43%

43%

44%

Haircare products and styling tools

22%

21%

21%

20%

Skincare

17%

17%

17%

18%

Fragrance and bath

12%

12%

12%

11%

Services

4%

4%

4%

4%

Accessories and other

3%

3%

3%

3%

100%

100%

100%

100%

Deferred revenue

Deferred revenue primarily represents contract liabilities for the obligation to transfer additional goods or services to a guest for which the Company has received consideration, such as unredeemed Ultamate Rewards loyalty points and unredeemed Ulta Beauty gift cards. In addition, breakage on gift cards is recognized proportionately as redemption occurs.

The following table provides a summary of the changes included in deferred revenue during the 13 and 26 weeks ended July 30, 2022 and July 31, 2021:

13 Weeks Ended

26 Weeks Ended

July 30,

July 31,

July 30,

July 31,

(In thousands)

2022

2021

2022

    

2021

Beginning balance

$

312,359

$

253,172

$

345,206

$

269,032

Additions to contract liabilities (1)

101,904

91,824

213,678

183,929

Deductions to contract liabilities (2)

(108,350)

(88,769)

(252,971)

(196,734)

Ending balance

$

305,913

$

256,227

$

305,913

$

256,227

(1)Loyalty points and gift cards issued in the current period but not redeemed or expired.
(2)Revenue recognized in the current period related to the beginning liability.

Other amounts included in deferred revenue were $10,658 and $9,235 at July 30, 2022 and July 31, 2021, respectively.

4.Goodwill and other intangible assets

Goodwill, which represents the excess of cost over the fair value of net assets acquired, was $10,870 at July 30, 2022, January 29, 2022, and July 31, 2021. No additional goodwill was recognized during the 13 and 26 weeks ended July 30, 2022. The recoverability of goodwill is reviewed annually during the fourth quarter or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.

10

Table of Contents

Other definite-lived intangible assets are amortized over their useful lives. The recoverability of intangible assets is reviewed whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable.

5.Leases

The Company leases retail stores, distribution centers, fast fulfillment centers, corporate offices, and certain equipment under non-cancelable operating leases with various expiration dates through 2034. All leases are classified as operating leases and generally have initial lease terms of 10 years and, when determined applicable, include renewal options under substantially the same terms and conditions as the original leases. Leases do not contain any material residual value guarantees or material restrictive covenants.

Lease cost

The majority of operating lease cost relates to retail stores, distribution centers, and fast fulfillment centers and is classified within cost of sales. Operating lease cost for corporate offices is classified within selling, general and administrative expenses. Operating lease cost from the control date through store opening date is classified within pre-opening expenses.

The following table presents a summary of operating lease costs:

13 Weeks Ended

26 Weeks Ended

July 30,

July 31,

July 30,

July 31,

(In thousands)

2022

2021

2022

2021

Operating lease cost

$

79,094

$

76,776

$

159,995

$

155,512

Other information

The following table presents supplemental disclosures of cash flow information related to operating leases:

    

26 Weeks Ended

July 30,

July 31,

(In thousands)

    

2022

2021

Cash paid for operating lease liabilities (1)

$

189,938

$

182,161

Operating lease assets obtained in exchange for operating lease liabilities (non-cash)

173,241

103,073

(1)Excludes $13,363 and $16,923 related to cash received for tenant incentives for the 26 weeks ended July 30, 2022 and July 31, 2021, respectively.

6.Commitments and contingencies

The Company is involved in various legal proceedings that are incidental to the conduct of the business including both class action and single plaintiff litigation. In the opinion of management, the amount of any liability with respect to these proceedings, either individually or in the aggregate, will not have a material adverse effect on the consolidated financial position, results of operations or cash flows.

7.Debt

On March 11, 2020, the Company entered into Amendment No. 1 to the Second Amended and Restated Loan Agreement (as so amended, the Loan Agreement) with Wells Fargo Bank, National Association, as Administrative Agent, Collateral Agent and a Lender thereunder; Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as Lead Arrangers and Bookrunners; JPMorgan Chase Bank, N.A., as Syndication Agent and a Lender; PNC Bank, National Association, as Documentation Agent and a Lender; and the other lenders party thereto. The Loan Agreement matures on March 11, 2025, provides maximum revolving loans equal to the lesser of $1,000,000 or a percentage of eligible owned

11

Table of Contents

inventory and eligible owned receivables (which borrowing base may, at the election of the Company and satisfaction of certain conditions, include a percentage of qualified cash), contains a $50,000 subfacility for letters of credit and allows the Company to increase the revolving facility by an additional $100,000, subject to the consent by each lender and other conditions. The Loan Agreement contains a requirement to maintain a fixed charge coverage ratio of not less than 1.0 to 1.0 during such periods when availability under the Loan Agreement falls below a specified threshold. Substantially all of the Company’s assets are pledged as collateral for outstanding borrowings under the Loan Agreement. Outstanding borrowings bear interest, at the Company’s election, at either a base rate plus a margin of 0% to 0.125% or the London Interbank Offered Rate plus a margin of 1.125% to 1.250%, with such margins based on the Company’s borrowing availability, and the unused line fee is 0.20% per annum.

As of July 30, 2022, January 29, 2022, and July 31, 2021, there were no borrowings outstanding under the credit facility.

As of July 30, 2022, the Company was in compliance with all terms and covenants of the Loan Agreement.

8.Fair value measurements

The carrying value of cash and cash equivalents, accounts receivable, and accounts payable approximates their estimated fair values due to the short maturities of these instruments.

Fair value is measured using inputs from the three levels of the fair value hierarchy, which are described as follows:

Level 1 – observable inputs such as quoted prices for identical instruments in active markets.
Level 2 – inputs other than quoted prices in active markets that are observable either directly or indirectly through corroboration with observable market data.
Level 3 – unobservable inputs in which there is little or no market data, which would require the Company to develop its own assumptions.

As of July 30, 2022, January 29, 2022, and July 31, 2021, there were liabilities related to the non-qualified deferred compensation plan included in other long-term liabilities on the consolidated balance sheets of $36,071, $40,839, and $38,077, respectively. The liabilities are categorized as Level 2 as they are based on third-party reported values, which are based primarily on quoted market prices of underlying assets of the funds within the plan.

9.Stock-based compensation

Stock-based compensation expense is measured on the grant date based on the fair value of the award. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period for awards expected to vest. The estimated grant date fair value of stock options was determined using a Black-Scholes valuation model using the following weighted-average assumptions:

    

26 Weeks Ended

July 30,

July 31,

    

2022

    

2021

Volatility rate

 

49.0%

46.9%

Average risk-free interest rate

 

2.4%

0.4%

Average expected life (in years)

 

3.4

 

3.9

Dividend yield

 

None

 

None

The expected volatility is based on the historical volatility of the Company’s common stock. The risk-free interest rate is based on the United States Treasury yield curve in effect on the date of grant for the respective expected life of the option. The expected life represents the time the options granted are expected to be outstanding. The expected life of options granted is derived from historical data on Ulta Beauty stock option exercises. Forfeitures of stock options are estimated at the grant date based on historical rates of stock option activity and reduce the stock-based compensation expense recognized. The Company does not currently pay a regular dividend.

12

Table of Contents

The Company granted 48 and 61 stock options during the 26 weeks ended July 30, 2022 and July 31, 2021, respectively. Stock-based compensation expense for stock options was $2,164 and $3,101 for the 13 weeks ended July 30, 2022 and July 31, 2021, respectively. Stock-based compensation expense for stock options was $4,506 and $5,998 for the 26 weeks ended July 30, 2022 and July 31, 2021, respectively. The weighted-average grant date fair value of these stock options was $149.14 and $109.72 for the 26 weeks ended July 30, 2022 and July 31, 2021, respectively. At July 30, 2022, there was approximately $13,822 of unrecognized stock-based compensation expense related to unvested stock options.

There were 56 and 58 restricted stock units issued during the 26 weeks ended July 30, 2022 and July 31, 2021, respectively. Stock-based compensation expense for restricted stock units was $4,987 and $5,149 for the 13 weeks ended July 30, 2022 and July 31, 2021, respectively. Stock-based compensation expense for restricted stock units was $9,439 and $9,984 for the 26 weeks ended July 30, 2022 and July 31, 2021, respectively. At July 30, 2022, there was approximately $32,535 of unrecognized stock-based compensation expense related to restricted stock